Paper41997488
Generation of G9 genotype porcine rotavirus using reverse genetics system and its application for antiviral screen and vaccine development.
Han N and 14 others. Virol Sin, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Generation of G9 genotype porcine rotavirus using reverse genetics system and its application for antiviral screen and vaccine development. Papers, record 41997488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41997488
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Generation of G9 genotype porcine rotavirus using reverse genetics system and its application for antiviral screen and vaccine development.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Rotavirus | Major topic |
| Reverse Genetics | Major topic |
| Rotavirus Infections | Major topic |
| Antiviral Agents | Major topic |
| Vaccine Development | Major topic |
| Swine Diseases | Major topic |
| Rotavirus Vaccines | Major topic |
| Animals | |
| Genotype | |
| Swine | |
| Mice | |
| Antibodies, Viral | |
| Antigens, Viral | |
| Reassortant Viruses | |
| China |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,640,212 | Synthesis and In Vitro Anti-Influenza Virus Evaluation of Novel Sialic Acid (C-5 and C-9)-Pentacyclic Triterpene Derivatives. | Molecules | 2017 | https://conductscience.org/library/papers/28640212 | PubMed |
| 2 | 30,616,694 | Development of a live attenuated trivalent porcine rotavirus A vaccine against disease caused by recent strains most prevalent in South Korea. | Vet Res | 2019 | https://conductscience.org/library/papers/30616694 | PubMed |
| 3 | 33,440,223 | Rotavirus reverse genetics systems: Development and application. | Virus Res | 2021 | https://conductscience.org/library/papers/33440223 | PubMed |
| 4 | 38,488,360 | Lipidomics reveals the significance and mechanism of the cellular ceramide metabolism for rotavirus replication. | J Virol | 2024 | https://conductscience.org/library/papers/38488360 | PubMed |
| 5 | 33,087,468 | Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus. | J Virol | 2020 | https://conductscience.org/library/papers/33087468 | PubMed |
| 6 | 8,904,456 | Isolation of group B porcine rotavirus in cell culture. | J Clin Microbiol | 1996 | https://conductscience.org/library/papers/8904456 | PubMed |
| 7 | 34,418,579 | iTRAQ-based proteome analysis of porcine group A rotavirus-infected porcine IPEC-J2 intestinal epithelial cells. | J Proteomics | 2021 | https://conductscience.org/library/papers/34418579 | PubMed |
| 8 | 30,105,384 | Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years. | JAMA Pediatr | 2018 | https://conductscience.org/library/papers/30105384 | PubMed |
| 9 | 35,038,906 | JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis. | mBio | 2022 | https://conductscience.org/library/papers/35038906 | PubMed |
| 10 | 31,597,761 | Generation of Recombinant Rotavirus Expressing NSP3-UnaG Fusion Protein by a Simplified Reverse Genetics System. | J Virol | 2019 | https://conductscience.org/library/papers/31597761 | PubMed |
| 11 | 38,467,166 | Isolation and characterization of a G9P[23] porcine rotavirus strain AHFY2022 in China. | Microb Pathog | 2024 | https://conductscience.org/library/papers/38467166 | PubMed |
| 12 | 39,064,870 | Principal Bioactive Properties of Oleanolic Acid, Its Derivatives, and Analogues. | Molecules | 2024 | https://conductscience.org/library/papers/39064870 | PubMed |
| 13 | 39,205,172 | Generation of Recombinant Authentic Live Attenuated Human Rotavirus Vaccine Strain RIX4414 (Rotarix®) from Cloned cDNAs Using Reverse Genetics. | Viruses | 2024 | https://conductscience.org/library/papers/39205172 | PubMed |
| 14 | 35,749,287 | Establishment of a reverse genetics system for avian rotavirus A strain PO-13. | J Gen Virol | 2022 | https://conductscience.org/library/papers/35749287 | PubMed |
| 15 | 30,160,138 | Diversity of group A rotavirus of porcine rotavirus in Shandong province China. | Acta Virol | 2018 | https://conductscience.org/library/papers/30160138 | PubMed |
| 16 | 39,610,277 | Establishment of a Reverse Genetics System for Rotavirus Vaccine Strain LLR and Developing Vaccine Candidates Carrying VP7 Gene Cloned From Human Strains Circulating in China. | J Med Virol | 2024 | https://conductscience.org/library/papers/39610277 | PubMed |
| 17 | 38,543,818 | Recent Molecular Characterization of Porcine Rotaviruses Detected in China and Their Phylogenetic Relationships with Human Rotaviruses. | Viruses | 2024 | https://conductscience.org/library/papers/38543818 | PubMed |
| 18 | 35,758,692 | Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes. | J Virol | 2022 | https://conductscience.org/library/papers/35758692 | PubMed |
| 19 | 36,748,482 | A reverse genetics system for human rotavirus G2P[4]. | J Gen Virol | 2022 | https://conductscience.org/library/papers/36748482 | PubMed |
| 20 | 31,645,445 | Reverse Genetics System for a Human Group A Rotavirus. | J Virol | 2020 | https://conductscience.org/library/papers/31645445 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41997488
GET https://conductscience.org/api/papers/v1/41997488/references?page=2